CAM2029, Octreotide LAR, Lanreotide ATG — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07 (month) in 9d
ESTIMATED |
READOUT
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patien
Phase 3 · Gastro-enteropancreatic Neuroendocrine Tumor |
Camurus AB | CAM2029, Octreotide LAR, Lanreotide ATG |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|